Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Scientific Reports, 2026

Profiling of immunomodulatory anti-cytokine autoantibodies associated with disease heterogeneity in a multiethnic Asian cohort

Shunmuganathan B., Gupta R., Teng O. et al.

International Journal of Infectious Diseases, 2026

Evaluating Mucosal and Systemic Immunity in an Observational Cohort of South African Children Hospitalised with Acute Respiratory Tract Infections

van Weelden G., Rabie H., Redfern A. et al.

Cardiovascular Diabetology, 2026

Targeted proteomics of extreme vascular phenotypes in type 1 diabetes: the ESCAPER study

Ekström O., Kennbäck C., Lyssenko V. et al.

Cureus, 2026

Differential Proteomic Response to Smoking Exposure Underlies Reduced Parkinson’s Disease Risk in Women

Lehrer S., Rheinstein P.

Brain and Behavior, 2026

APOE and Cerebral Microbleeds: Insights Into Causal Proteins and Therapeutic Targets

Yang L., Zhao J., Song J. et al.

NeuroMolecular Medicine, 2026

Association of Cathepsin Proteins with Alzheimer's Disease Risk: An Integrated Observational and Genetic Analysis

Zhang Q., Li Q., Ai Z. et al.

Cancer Prevention Research, 2026

Simvastatin Treatment in Patients with Liver Cirrhosis: A Phase II Randomized Placebo-Controlled Trial Shows Reduction in IL6 Levels

Hussain S., Ayoub W., Cruz-Correa M. et al.

Scientific Reports, 2026

Cardiovascular peptide markers are associated with age-related macular degeneration in the Bialystok PLUS general population cohort

Budnik A., Tuchliński J., Lisowski ?. et al.

Science Translational Medicine, 2026

Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17–driven endothelial activation

Karagkouni D., Brake M., Patell R. et al.

Biomedicines, 2026

Adverse Early-Life Factors Associated with Clonal Hematopoiesis of Indeterminate Potential in Later Life

Yu Y., Wang J., Sun Y. et al.

Clinical Cancer Research, 2026

A multicentre phase 2 study of trifluridine/tipiracil in recurrent/metastatic platinum resistant nasopharyngeal carcinomas

Low J., Chong W., Hui E. et al.

Expert Review of Molecular Diagnostics, 2026

Neuro-axonal injury biomarker serum neurofilament light chain is associated with osteoarthritis: a dual-cohort study from NHANES and UK Biobank

Liu M., Ma H., Zhou H. et al.

Kidney Medicine, 2026

Association of Cystatin C- and Creatinine-Based eGFR With Adverse Outcomes in Heart Failure With Preserved Ejection Fraction

Roehm B., Zhang X., Yang J. et al.

Psychiatry Research, 2026

Bayesian colocalization of psychiatric disorder GWAS signals with molecular quantitative trait loci highlights histone involvement and neuroimmune dysregulation in pathogenesis

Ryu J., Lee C.

Nature Medicine, 2026

Plasma proteomic signatures of cellular aging predict human disease

Ding D., Bot V., Chen K. et al.

Eurasia Journal of Science and Technology, 2026

PLASMA PROTEIN LEVEL RATIOS IDENTIFY NOVEL CIRCULATING TARGETS ASSOCIATED WITH STROKE RISK

Wang Q., Jin T., Gu J. et al.

Annals of the Rheumatic Diseases, 2026

Longitudinal profiling reveals immune dynamics and distinct plasma cell signatures during B-cell depletion in IgG4-related disease

Kim H., Kim M., Kim S. et al.

Journal of the National Cancer Center, 2026

Systemic inflammatory protein signatures associated with gastric lesion progression and risk of gastric cancer

Yang L., Xu H., Zhang C. et al.

Journal of Global Health, 2026

Plasma proteomic signatures predict incident benign prostatic hyperplasia: a prospective cohort study of 20 996 men

Li H., Zhang Y., Chen L. et al.

Cardiovascular Diabetology, 2026

Growth differentiation factor-15 and the incidence, bidirectional progression, and risk prediction of atherosclerotic cardiovascular disease and metabolic dysfunction-associated steatotic liver disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3

Chen X., Tang H., Xu Z. et al.

4626 publications